Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for pulmonary hypertension in fibrotic lung disease
2007-001643-21Phase 4Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of bosentan in pulmonary hypertension (PH) and interstitial lung disease (ILD), sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Change in pulmonary vascular resistance. Started Oct 2007; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension (PH)interstitial lung disease (ILD)
Beyond the preview
Go deeper on 2007-001643-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001643-21.